UTHealth joins trial to test antibodies and other experimental outpatient COVID treatments

A study on the effectiveness of multiple treatments, including laboratory-made antibodies, at preventing mild COVID-19 from advancing to severe illness in the outpatient setting is underway by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital. UTHealth is…

Details

With digital phenotyping, smartphones may play a role in assessing severe mental illness

September 15, 2020 – Digital phenotyping approaches that collect and analyze Smartphone-user data on locations, activities, and even feelings – combined with machine learning to recognize patterns and make predictions from the data – have emerged as promising tools for monitoring patients with psychosis spectrum illnesses, according to a report in the September/October issue of…

Details